PetMed Express, Inc.
PetMed Express, Inc.
Your view on PETS
Overview
What the company does, where it operates, and who runs it.
About PetMed Express, Inc.
- Industry
- Specialty Retail
- Sector
- Consumer Cyclical
- CEO
- Leslie C. G. Campbell
- Headquarters
- 420 South Congress Avenue, Delray Beach, FL, US
- Industry
- Specialty Retail
- Sector
- Consumer Cyclical
- CEO
- Leslie C. G. Campbell
- Headquarters
- 420 South Congress Avenue, Delray Beach, FL, US
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.
It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
The company also sells food, beds, crates, stairs, and other pet supplies.
It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for PetMed Express, Inc., and the rating behind it. PETS last traded at $1.16; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for PetMed Express, Inc.. Starting points for PetMed Express, Inc.: EPS -$1.35, beta 0.84 — an Specialty Retail name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for PetMed Express, Inc.. PetMed Express, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for PetMed Express, Inc.. Trailing twelve-month EPS for PetMed Express, Inc. stands at -$1.35. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for PetMed Express, Inc.. PetMed Express, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
PetMed Express, Inc. valued side by side against its closest peers. PetMed Express, Inc. is measured against Specialty Retail peers within the Consumer Cyclical sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold PetMed Express, Inc., and how their positions are changing. At a $25.1M market value, institutional positions materially move PetMed Express, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by PetMed Express, Inc. executives and directors. Shares of PetMed Express, Inc. have traded between $1.85 and $6.85 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming PetMed Express, Inc.. PetMed Express, Inc. is a $25.1M Consumer Cyclical company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming PetMed Express, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for PetMed Express, Inc.. Coverage tracks PetMed Express, Inc. within Specialty Retail (Consumer Cyclical). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.